Glycosylated Fibronectin as a wide-spectrum biomarker in pregnancy

Dimitrios Karoutsos, Zacharias Fasoulakis, Stavroula Michala, Konstantinos Stefanidis, Panagiotis Antsaklis

Glycosylated Fibronectin (GFN), a glycoprotein involved in cell adhesion and migration, has been implicated in several physiological and pathological processes. Current literature suggests its altered glycosylation patterns might be associated with various pregnancy complications with recent studies providing new empirical evidence …

Posted in 2023 Volume 22 – Issue 3 Tagged , , , ,

Glycosylated Fibronectin as a wide-spectrum biomarker in pregnancy

D. Karoutsos, Z. Fasoulakis, S. Michala, K. Stefanidis, P. Antsaklis

Glycosylated Fibronectin (GFN), a glycoprotein involved in cell adhesion and migration, has been implicated in several physiological and pathological processes. Current literature suggests its altered glycosylation patterns might be associated with various pregnancy complications with recent studies providing new empirical evidence from a cohort study …

Posted in 2023 Volume 22 – Issue 2 Tagged , , , ,

Proteomics and gynecological cancer

Makedou K, Prapas N, Kourtis A, Makedos G

Proteomics is the study of the complete protein complement of the human genome, the “proteome”. Various technologies have been developed for the purposes of proteomics, such as mass spectrometry. In oncology, proteomics can provide the identification of a panel of proteins, which can be used as biomarkers for early cancer detection, for disease stage determination, for the application …

Posted in 2008 Volume 7 – Issue 4 Tagged , , , ,